| 0 |
APPLICATION SITE HYPERTROPHY |
1 |
0.0714 |
| 1 |
MEDIASTINAL CYST |
1 |
0.0556 |
| 2 |
GALLBLADDER ADENOCARCINOMA |
3 |
0.0423 |
| 3 |
HER2 POSITIVE GASTRIC CANCER |
1 |
0.0312 |
| 4 |
ACTIVATED PROTEIN C RESISTANCE |
1 |
0.0303 |
| 5 |
ACANTHAMOEBA KERATITIS |
1 |
0.0270 |
| 6 |
GIANT PAPILLARY CONJUNCTIVITIS |
1 |
0.0200 |
| 7 |
TISSUE DISCOLOURATION |
1 |
0.0175 |
| 8 |
FOREIGN BODY IN SKIN OR SUBCUTANEOUS TISSUE |
1 |
0.0145 |
| 9 |
BONE MARROW LEUKAEMIC CELL INFILTRATION |
1 |
0.0122 |
| 10 |
PRIMARY EFFUSION LYMPHOMA |
1 |
0.0116 |
| 11 |
PERICORONITIS |
1 |
0.0110 |
| 12 |
PSEUDOCHOLELITHIASIS |
1 |
0.0093 |
| 13 |
PROPIONIBACTERIUM INFECTION |
1 |
0.0093 |
| 14 |
APPLICATION SITE NODULE |
1 |
0.0073 |
| 15 |
LIMB FRACTURE |
1 |
0.0067 |
| 16 |
APPLICATION SITE WOUND |
1 |
0.0061 |
| 17 |
TANGENTIALITY |
1 |
0.0052 |
| 18 |
XANTHOMA |
1 |
0.0050 |
| 19 |
VOCAL CORD PARESIS |
1 |
0.0043 |
| 20 |
INFECTIVE SPONDYLITIS |
1 |
0.0041 |
| 21 |
ANTICOAGULANT THERAPY |
1 |
0.0035 |
| 22 |
BLADDER TAMPONADE |
1 |
0.0033 |
| 23 |
CONTRAINDICATED DEVICE USED |
1 |
0.0031 |
| 24 |
TINEA VERSICOLOUR |
1 |
0.0028 |
| 25 |
INFECTED DERMAL CYST |
1 |
0.0028 |
| 26 |
PORTAL VENOUS GAS |
1 |
0.0028 |
| 27 |
SYPHILIS |
2 |
0.0028 |
| 28 |
BOVINE TUBERCULOSIS |
1 |
0.0026 |
| 29 |
TISSUE INJURY |
1 |
0.0023 |
| 30 |
SEXUAL ABUSE |
1 |
0.0023 |
| 31 |
ECZEMA ASTEATOTIC |
1 |
0.0021 |
| 32 |
STATUS ASTHMATICUS |
1 |
0.0021 |
| 33 |
GRAFT VERSUS HOST DISEASE IN LUNG |
1 |
0.0021 |
| 34 |
DRAINAGE |
1 |
0.0020 |
| 35 |
WATER INTOXICATION |
1 |
0.0020 |
| 36 |
APPLICATION SITE INFECTION |
1 |
0.0020 |
| 37 |
EYE INFECTION BACTERIAL |
1 |
0.0018 |
| 38 |
NAIL DYSTROPHY |
1 |
0.0018 |
| 39 |
CORNEAL EPITHELIUM DEFECT |
1 |
0.0017 |
| 40 |
PAROTID GLAND ENLARGEMENT |
1 |
0.0015 |
| 41 |
PELVIC FLUID COLLECTION |
1 |
0.0014 |
| 42 |
LIP EROSION |
1 |
0.0014 |
| 43 |
REFLUX OESOPHAGITIS |
1 |
0.0013 |
| 44 |
HERPES ZOSTER DISSEMINATED |
1 |
0.0012 |
| 45 |
BARRETT'S OESOPHAGUS |
1 |
0.0012 |
| 46 |
ABDOMINAL SYMPTOM |
1 |
0.0012 |
| 47 |
ALCOHOL WITHDRAWAL SYNDROME |
1 |
0.0011 |
| 48 |
HILAR LYMPHADENOPATHY |
1 |
0.0011 |
| 49 |
ADENOCARCINOMA OF COLON |
2 |
0.0011 |
| 50 |
NEUROENDOCRINE CARCINOMA OF THE SKIN |
1 |
0.0010 |
| 51 |
MUCOSAL DISORDER |
1 |
0.0010 |
| 52 |
REDUCED FACIAL EXPRESSION |
1 |
0.0010 |
| 53 |
NON-CARDIOGENIC PULMONARY OEDEMA |
1 |
0.0009 |
| 54 |
CARDIAC HYPERTROPHY |
1 |
0.0009 |
| 55 |
HYPERSENSITIVITY PNEUMONITIS |
1 |
0.0009 |
| 56 |
APPLICATION SITE DISCHARGE |
1 |
0.0009 |
| 57 |
ISCHAEMIC CEREBRAL INFARCTION |
1 |
0.0009 |
| 58 |
PULMONARY INFARCTION |
2 |
0.0008 |
| 59 |
PHARYNGEAL INFLAMMATION |
1 |
0.0008 |
| 60 |
APPLICATION SITE SCAR |
1 |
0.0008 |
| 61 |
IMMUNE RECONSTITUTION SYNDROME |
1 |
0.0008 |
| 62 |
TUMOUR PAIN |
1 |
0.0008 |
| 63 |
NAIL INFECTION |
1 |
0.0007 |
| 64 |
NOROVIRUS INFECTION |
1 |
0.0007 |
| 65 |
SEBORRHOEIC KERATOSIS |
1 |
0.0007 |
| 66 |
PNEUMONIA PNEUMOCOCCAL |
1 |
0.0007 |
| 67 |
SMALL CELL LUNG CANCER |
1 |
0.0007 |
| 68 |
INFECTIOUS PLEURAL EFFUSION |
1 |
0.0007 |
| 69 |
VASCULAR RUPTURE |
1 |
0.0006 |
| 70 |
SYSTEMIC INFECTION |
1 |
0.0006 |
| 71 |
SALMONELLOSIS |
1 |
0.0006 |
| 72 |
ENTERITIS INFECTIOUS |
1 |
0.0006 |
| 73 |
WOUND COMPLICATION |
2 |
0.0006 |
| 74 |
LIVER TRANSPLANT REJECTION |
1 |
0.0006 |
| 75 |
LOBAR PNEUMONIA |
1 |
0.0005 |
| 76 |
PSYCHIATRIC DECOMPENSATION |
1 |
0.0005 |
| 77 |
OESOPHAGEAL CANDIDIASIS |
2 |
0.0005 |
| 78 |
HYPOPHYSITIS |
1 |
0.0005 |
| 79 |
RENAL HAEMORRHAGE |
1 |
0.0005 |
| 80 |
VENOUS THROMBOSIS LIMB |
1 |
0.0005 |
| 81 |
SKIN INDURATION |
1 |
0.0005 |
| 82 |
LUNG ABSCESS |
1 |
0.0005 |
| 83 |
PERIODONTITIS |
1 |
0.0005 |
| 84 |
CERVICAL DYSPLASIA |
1 |
0.0005 |
| 85 |
REACTION TO EXCIPIENT |
1 |
0.0004 |
| 86 |
LYMPHADENITIS |
1 |
0.0004 |
| 87 |
METASTASES TO PERITONEUM |
1 |
0.0004 |
| 88 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
17 |
0.0004 |
| 89 |
LUNG OPACITY |
1 |
0.0004 |
| 90 |
ALCOHOL POISONING |
1 |
0.0004 |
| 91 |
SHOCK HAEMORRHAGIC |
3 |
0.0004 |
| 92 |
GASTRIC ULCER HAEMORRHAGE |
2 |
0.0004 |
| 93 |
PROCTITIS |
1 |
0.0004 |
| 94 |
HYPERTONIC BLADDER |
1 |
0.0003 |
| 95 |
HISTIOCYTOSIS HAEMATOPHAGIC |
1 |
0.0003 |
| 96 |
CONTRAINDICATED PRODUCT ADMINISTERED |
10 |
0.0003 |
| 97 |
KERATITIS |
1 |
0.0003 |
| 98 |
MEDICAL DEVICE DISCOMFORT |
1 |
0.0003 |
| 99 |
PNEUMONIA VIRAL |
1 |
0.0003 |
| 100 |
ORAL CANDIDIASIS |
4 |
0.0003 |
| 101 |
POTENTIATING DRUG INTERACTION |
1 |
0.0003 |
| 102 |
DERMATITIS EXFOLIATIVE GENERALISED |
1 |
0.0003 |
| 103 |
SKIN WEEPING |
1 |
0.0003 |
| 104 |
APPLICATION SITE PAIN |
6 |
0.0003 |
| 105 |
DUODENAL ULCER PERFORATION |
2 |
0.0003 |
| 106 |
LEUKOENCEPHALOPATHY |
1 |
0.0003 |
| 107 |
BRONCHOPULMONARY ASPERGILLOSIS |
2 |
0.0003 |
| 108 |
HYPOALBUMINAEMIA |
2 |
0.0003 |
| 109 |
PROCEDURAL HAEMORRHAGE |
1 |
0.0003 |
| 110 |
AZOTAEMIA |
1 |
0.0003 |
| 111 |
CYSTITIS HAEMORRHAGIC |
1 |
0.0002 |
| 112 |
HYPERURICAEMIA |
1 |
0.0002 |
| 113 |
CYTOMEGALOVIRUS VIRAEMIA |
1 |
0.0002 |
| 114 |
NEPHROGENIC ANAEMIA |
1 |
0.0002 |
| 115 |
NON-SMALL CELL LUNG CANCER |
1 |
0.0002 |
| 116 |
KIDNEY TRANSPLANT REJECTION |
1 |
0.0002 |
| 117 |
HUMERUS FRACTURE |
1 |
0.0002 |
| 118 |
INCORRECT DOSAGE ADMINISTERED |
1 |
0.0002 |
| 119 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
1 |
0.0002 |
| 120 |
APPLICATION SITE SWELLING |
1 |
0.0002 |
| 121 |
DYSLIPIDAEMIA |
1 |
0.0002 |
| 122 |
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER |
1 |
0.0002 |
| 123 |
SERUM FERRITIN INCREASED |
1 |
0.0002 |
| 124 |
ANAL ABSCESS |
1 |
0.0002 |
| 125 |
GINGIVITIS |
1 |
0.0002 |
| 126 |
HIP SURGERY |
1 |
0.0002 |
| 127 |
NONSPECIFIC REACTION |
1 |
0.0002 |
| 128 |
ENTEROCOLITIS |
1 |
0.0002 |
| 129 |
METASTASES TO LIVER |
3 |
0.0002 |
| 130 |
BRADYKINESIA |
1 |
0.0002 |
| 131 |
PLEURISY |
1 |
0.0002 |
| 132 |
TYPE 1 DIABETES MELLITUS |
1 |
0.0002 |
| 133 |
VULVOVAGINAL BURNING SENSATION |
1 |
0.0002 |
| 134 |
APPLICATION SITE IRRITATION |
2 |
0.0002 |
| 135 |
PROCTALGIA |
1 |
0.0002 |
| 136 |
UVEITIS |
2 |
0.0001 |
| 137 |
ENCEPHALITIS |
1 |
0.0001 |
| 138 |
PULMONARY TOXICITY |
1 |
0.0001 |
| 139 |
HAND FRACTURE |
1 |
0.0001 |
| 140 |
GRAFT VERSUS HOST DISEASE |
1 |
0.0001 |
| 141 |
FAECES SOFT |
1 |
0.0001 |
| 142 |
GASTROENTERITIS |
2 |
0.0001 |
| 143 |
DIFFUSE LARGE B-CELL LYMPHOMA |
1 |
0.0001 |
| 144 |
HAEMOLYSIS |
1 |
0.0001 |
| 145 |
ACUTE MYELOID LEUKAEMIA |
2 |
0.0001 |
| 146 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
2 |
0.0001 |
| 147 |
RHINITIS |
1 |
0.0001 |
| 148 |
HAEMODIALYSIS |
1 |
0.0001 |
| 149 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
2 |
0.0001 |
| 150 |
APPLICATION SITE ERYTHEMA |
3 |
0.0001 |
| 151 |
DRUG ERUPTION |
2 |
0.0001 |
| 152 |
OSTEOMYELITIS |
2 |
0.0001 |
| 153 |
HYPERSENSITIVITY |
20 |
0.0001 |
| 154 |
HEPATIC ENCEPHALOPATHY |
1 |
0.0001 |
| 155 |
ARTERIOSCLEROSIS |
1 |
0.0001 |
| 156 |
HYPERCHOLESTEROLAEMIA |
1 |
0.0001 |
| 157 |
THROMBOTIC MICROANGIOPATHY |
1 |
0.0001 |
| 158 |
KNEE OPERATION |
1 |
0.0001 |
| 159 |
OVARIAN CYST |
1 |
0.0001 |
| 160 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
1 |
0.0001 |
| 161 |
TOXIC SKIN ERUPTION |
1 |
0.0001 |
| 162 |
VAGINAL DISCHARGE |
1 |
0.0001 |
| 163 |
EYE DISCHARGE |
1 |
0.0001 |
| 164 |
FOLLICULITIS |
1 |
0.0001 |
| 165 |
SKIN LACERATION |
1 |
0.0001 |
| 166 |
WOUND INFECTION |
1 |
0.0001 |
| 167 |
DENTAL CARIES |
1 |
0.0001 |
| 168 |
MALNUTRITION |
1 |
0.0001 |
| 169 |
DERMATITIS CONTACT |
1 |
0.0001 |
| 170 |
BACTERAEMIA |
1 |
0.0001 |
| 171 |
MUSCLE RIGIDITY |
1 |
0.0001 |
| 172 |
CYTOPENIA |
1 |
0.0001 |
| 173 |
OSTEONECROSIS OF JAW |
2 |
0.0001 |
| 174 |
GENERALISED OEDEMA |
1 |
0.0001 |
| 175 |
PHARYNGITIS |
1 |
0.0001 |
| 176 |
HEPATIC FUNCTION ABNORMAL |
3 |
0.0001 |
| 177 |
PNEUMONIA ASPIRATION |
2 |
0.0001 |
| 178 |
DYSMENORRHOEA |
1 |
0.0001 |
| 179 |
EYE HAEMORRHAGE |
1 |
0.0001 |
| 180 |
LUNG NEOPLASM MALIGNANT |
3 |
0.0001 |
| 181 |
DISSEMINATED INTRAVASCULAR COAGULATION |
1 |
0.0001 |
| 182 |
LYMPHOPENIA |
1 |
0.0001 |
| 183 |
CARDIOGENIC SHOCK |
1 |
0.0001 |
| 184 |
SKIN DISCOLOURATION |
3 |
0.0001 |
| 185 |
TENDONITIS |
1 |
0.0001 |
| 186 |
PNEUMOTHORAX |
1 |
0.0001 |
| 187 |
ABSCESS |
1 |
0.0001 |
| 188 |
INTERSTITIAL LUNG DISEASE |
3 |
0.0001 |
| 189 |
METASTASES TO BONE |
1 |
0.0001 |
| 190 |
FACE OEDEMA |
1 |
0.0001 |
| 191 |
METRORRHAGIA |
1 |
0.0001 |
| 192 |
SCAR |
1 |
0.0001 |
| 193 |
ASPARTATE AMINOTRANSFERASE INCREASED |
3 |
0.0001 |
| 194 |
HEPATIC STEATOSIS |
1 |
0.0001 |
| 195 |
BACTERIAL INFECTION |
1 |
0.0001 |
| 196 |
FOOT FRACTURE |
1 |
0.0001 |
| 197 |
GASTRIC ULCER |
1 |
0.0001 |
| 198 |
PROTEINURIA |
1 |
0.0001 |
| 199 |
HAEMORRHOIDS |
1 |
0.0001 |
| 200 |
MENORRHAGIA |
1 |
0.0001 |
| 201 |
PRESCRIBED UNDERDOSE |
1 |
0.0001 |
| 202 |
CYTOKINE RELEASE SYNDROME |
1 |
0.0000 |
| 203 |
FULL BLOOD COUNT DECREASED |
1 |
0.0000 |
| 204 |
PRODUCT ADMINISTRATION ERROR |
1 |
0.0000 |
| 205 |
STOMATITIS |
3 |
0.0000 |
| 206 |
PLEURAL EFFUSION |
3 |
0.0000 |
| 207 |
BONE MARROW FAILURE |
1 |
0.0000 |
| 208 |
ALANINE AMINOTRANSFERASE INCREASED |
3 |
0.0000 |
| 209 |
PULMONARY HYPERTENSION |
1 |
0.0000 |
| 210 |
IRRITABLE BOWEL SYNDROME |
1 |
0.0000 |
| 211 |
SKIN CANCER |
1 |
0.0000 |
| 212 |
PRURITUS GENERALISED |
1 |
0.0000 |
| 213 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
1 |
0.0000 |
| 214 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
1 |
0.0000 |
| 215 |
TOOTH DISORDER |
1 |
0.0000 |
| 216 |
RASH MACULO-PAPULAR |
1 |
0.0000 |
| 217 |
COLITIS ULCERATIVE |
2 |
0.0000 |
| 218 |
PERICARDIAL EFFUSION |
1 |
0.0000 |
| 219 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
1 |
0.0000 |
| 220 |
OCULAR HYPERAEMIA |
2 |
0.0000 |
| 221 |
DISEASE RECURRENCE |
2 |
0.0000 |
| 222 |
PRODUCT COMPLAINT |
1 |
0.0000 |
| 223 |
HYPOPHAGIA |
1 |
0.0000 |
| 224 |
EXPOSURE VIA SKIN CONTACT |
1 |
0.0000 |
| 225 |
MUCOSAL INFLAMMATION |
1 |
0.0000 |
| 226 |
TREATMENT FAILURE |
3 |
0.0000 |
| 227 |
RHEUMATOID ARTHRITIS |
4 |
0.0000 |
| 228 |
EYE IRRITATION |
2 |
0.0000 |
| 229 |
PSYCHOTIC DISORDER |
1 |
0.0000 |
| 230 |
OESOPHAGEAL CARCINOMA |
1 |
0.0000 |
| 231 |
LACRIMATION INCREASED |
1 |
0.0000 |
| 232 |
DRUG-INDUCED LIVER INJURY |
1 |
0.0000 |
| 233 |
OSTEONECROSIS |
1 |
0.0000 |
| 234 |
NAUSEA |
24 |
0.0000 |
| 235 |
STAPHYLOCOCCAL INFECTION |
1 |
0.0000 |
| 236 |
HEADACHE |
19 |
0.0000 |
| 237 |
FEBRILE NEUTROPENIA |
2 |
0.0000 |
| 238 |
EYE PRURITUS |
1 |
0.0000 |
| 239 |
TYPE 2 DIABETES MELLITUS |
1 |
0.0000 |
| 240 |
SINUSITIS |
3 |
0.0000 |
| 241 |
BURNING SENSATION |
2 |
0.0000 |
| 242 |
HYPERKALAEMIA |
1 |
0.0000 |
| 243 |
PRODUCT ADHESION ISSUE |
1 |
0.0000 |
| 244 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
1 |
0.0000 |
| 245 |
C-REACTIVE PROTEIN INCREASED |
1 |
0.0000 |
| 246 |
COLITIS |
1 |
0.0000 |
| 247 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 248 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
1 |
0.0000 |
| 249 |
ABNORMAL BEHAVIOUR |
1 |
0.0000 |
| 250 |
DYSKINESIA |
1 |
0.0000 |
| 251 |
BLINDNESS |
1 |
0.0000 |
| 252 |
NEUTROPHIL COUNT DECREASED |
1 |
0.0000 |
| 253 |
CARDIO-RESPIRATORY ARREST |
1 |
0.0000 |
| 254 |
ROAD TRAFFIC ACCIDENT |
1 |
0.0000 |
| 255 |
RENAL IMPAIRMENT |
2 |
0.0000 |
| 256 |
HYPERTENSION |
5 |
0.0000 |
| 257 |
RENAL FAILURE |
3 |
0.0000 |
| 258 |
LIVER DISORDER |
1 |
0.0000 |
| 259 |
THROAT IRRITATION |
1 |
0.0000 |
| 260 |
HYPOKALAEMIA |
1 |
0.0000 |
| 261 |
UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 262 |
RENAL DISORDER |
1 |
0.0000 |
| 263 |
SWELLING |
2 |
0.0000 |
| 264 |
PULMONARY EMBOLISM |
2 |
0.0000 |
| 265 |
LEUKOPENIA |
1 |
0.0000 |
| 266 |
MALIGNANT NEOPLASM PROGRESSION |
2 |
0.0000 |
| 267 |
ECZEMA |
1 |
0.0000 |
| 268 |
DRUG EFFECT DECREASED |
1 |
0.0000 |
| 269 |
PNEUMONIA |
6 |
0.0000 |
| 270 |
WHITE BLOOD CELL COUNT DECREASED |
2 |
0.0000 |
| 271 |
TREATMENT NONCOMPLIANCE |
1 |
0.0000 |
| 272 |
ANAPHYLACTIC REACTION |
1 |
0.0000 |
| 273 |
SEPSIS |
2 |
0.0000 |
| 274 |
PANCYTOPENIA |
1 |
0.0000 |
| 275 |
BLISTER |
1 |
0.0000 |
| 276 |
EYE PAIN |
1 |
0.0000 |
| 277 |
HERPES ZOSTER |
1 |
0.0000 |
| 278 |
PYREXIA |
6 |
0.0000 |
| 279 |
ABDOMINAL PAIN |
4 |
0.0000 |
| 280 |
COVID-19 |
3 |
0.0000 |
| 281 |
SURGERY |
1 |
0.0000 |
| 282 |
BLADDER CANCER |
1 |
0.0000 |
| 283 |
CATARACT |
1 |
0.0000 |
| 284 |
FEELING HOT |
1 |
0.0000 |
| 285 |
ANAEMIA |
3 |
0.0000 |
| 286 |
RHINORRHOEA |
1 |
0.0000 |
| 287 |
DEVICE EXPULSION |
1 |
0.0000 |
| 288 |
DEEP VEIN THROMBOSIS |
1 |
0.0000 |
| 289 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 290 |
INFUSION RELATED REACTION |
1 |
0.0000 |
| 291 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 292 |
WEIGHT DECREASED |
4 |
0.0000 |
| 293 |
UNDERDOSE |
1 |
0.0000 |
| 294 |
BRONCHITIS |
1 |
0.0000 |
| 295 |
HALLUCINATION |
1 |
0.0000 |
| 296 |
HOT FLUSH |
1 |
0.0000 |
| 297 |
DIABETES MELLITUS |
1 |
0.0000 |
| 298 |
DECREASED APPETITE |
3 |
0.0000 |
| 299 |
ARTHRITIS |
1 |
0.0000 |
| 300 |
CARDIAC FAILURE |
1 |
0.0000 |
| 301 |
PROSTATE CANCER |
1 |
0.0000 |
| 302 |
TREMOR |
2 |
0.0000 |
| 303 |
FALL |
4 |
0.0000 |
| 304 |
URINARY TRACT INFECTION |
2 |
0.0000 |
| 305 |
INTENTIONAL PRODUCT MISUSE |
1 |
0.0000 |
| 306 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 307 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
2 |
0.0000 |
| 308 |
DIARRHOEA |
7 |
0.0000 |
| 309 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 310 |
GAIT DISTURBANCE |
2 |
0.0000 |
| 311 |
CONTUSION |
1 |
0.0000 |
| 312 |
DIZZINESS |
5 |
0.0000 |
| 313 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 314 |
ERYTHEMA |
2 |
0.0000 |
| 315 |
OVERDOSE |
2 |
0.0000 |
| 316 |
CONSTIPATION |
2 |
0.0000 |
| 317 |
ASTHMA |
1 |
0.0000 |
| 318 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 319 |
BACK PAIN |
2 |
0.0000 |
| 320 |
CHILLS |
1 |
0.0000 |
| 321 |
JOINT SWELLING |
1 |
0.0000 |
| 322 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 323 |
PRODUCT USE IN UNAPPROVED INDICATION |
2 |
0.0000 |
| 324 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 325 |
PSORIASIS |
1 |
0.0000 |
| 326 |
INSOMNIA |
2 |
0.0000 |
| 327 |
DEHYDRATION |
1 |
0.0000 |
| 328 |
DRY SKIN |
1 |
0.0000 |
| 329 |
PRODUCT QUALITY ISSUE |
1 |
0.0000 |
| 330 |
NEUTROPENIA |
1 |
0.0000 |
| 331 |
MEMORY IMPAIRMENT |
1 |
0.0000 |
| 332 |
ARTHRALGIA |
3 |
0.0000 |
| 333 |
COUGH |
2 |
0.0000 |
| 334 |
DEATH |
6 |
0.0000 |
| 335 |
OFF LABEL USE |
6 |
0.0000 |
| 336 |
HYPOAESTHESIA |
1 |
0.0000 |
| 337 |
CONDITION AGGRAVATED |
2 |
0.0000 |
| 338 |
PAIN |
4 |
0.0000 |
| 339 |
HOSPITALISATION |
1 |
0.0000 |
| 340 |
VOMITING |
3 |
0.0000 |
| 341 |
DRUG INTERACTION |
1 |
0.0000 |
| 342 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 343 |
ABDOMINAL DISCOMFORT |
1 |
0.0000 |
| 344 |
NASOPHARYNGITIS |
1 |
0.0000 |
| 345 |
CHEST PAIN |
1 |
0.0000 |
| 346 |
ASTHENIA |
2 |
0.0000 |
| 347 |
DRUG INEFFECTIVE |
7 |
0.0000 |
| 348 |
DYSPNOEA |
3 |
0.0000 |
| 349 |
PRURITUS |
2 |
0.0000 |
| 350 |
HYPOTENSION |
1 |
0.0000 |
| 351 |
SOMNOLENCE |
1 |
0.0000 |
| 352 |
ABDOMINAL PAIN UPPER |
1 |
0.0000 |
| 353 |
RASH |
2 |
0.0000 |
| 354 |
DEPRESSION |
1 |
0.0000 |
| 355 |
FEELING ABNORMAL |
1 |
0.0000 |
| 356 |
FATIGUE |
3 |
0.0000 |